THE OUTCOME OF PATIENTS WITH THYROID-CARCINOMA AND GRAVES-DISEASE

被引:41
|
作者
KASUGA, Y
SUGENOYA, A
KOBAYASHI, S
MASUDA, H
IIDA, F
机构
[1] The Department of Surgery, Shinshu University School of Medicine, Matsumoto, 390
来源
关键词
THYROID CARCINOMA; GRAVES DISEASE; THYROID STIMULATING ANTIBODY (TSAB);
D O I
10.1007/BF00308993
中图分类号
R61 [外科手术学];
学科分类号
摘要
A total 847 consecutive patients with Graves' disease who underwent thyroidectomy between 1965 and 1990 were found to have a 4.3% incidence of coincident carcinoma of the thyroid. In 68.2% of these cases the tumors were less than 1 cm in diameter and were detected in only 7 patients (19.4%) prior to surgery. Dissection of the regional lymph nodes was necessary in only 11 patients. A review of the patients in 1990 revealed no carcinoma-related deaths with metastases occurring most commonly in the patients with larger tumors and in those whose cancer had been detected prior to thyroidectomy. Although the detection of potential tumors occurring with Graves' disease using preoperative echogram may be of interest, our results suggest that occult micro-carcinoma occurring coincidentally with Graves' disease is not clinically significant as it did not cause any recurrence in this study. Moreover, there was no evidence to suggest that Graves' disease was associated with the increased or rapid growth of these tumors.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 50 条
  • [21] THYROID STIMULATING IMMUNOGLOBULINS IN GRAVES-DISEASE
    LUTTRELL, BM
    HALES, IB
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (03): : 293 - 298
  • [22] THYROID-SURGERY FOR GRAVES-DISEASE
    RICCABONA, G
    ACTA MEDICA AUSTRIACA, 1987, 14 (3-4) : 84 - 86
  • [23] THYROID STIMULATING AUTOANTIBODIES IN GRAVES-DISEASE
    SCHLEUSENER, H
    KOTULLA, P
    WENZEL, B
    ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY, 1979, 156 (03): : 181 - 181
  • [24] FOLLICULAR CARCINOMA OF THE THYROID FOLLOWING RADIOACTIVE IODINE TREATMENT FOR GRAVES-DISEASE
    STAFFURTH, JS
    HOLLALLEN, RTJ
    POSTGRADUATE MEDICAL JOURNAL, 1988, 64 (757) : 878 - 880
  • [25] HYPERTHYROIDISM WITH POTENT THYROID-STIMULATION-BLOCKING ANTIBODIES AND NEGATIVE THYROID-STIMULATING ANTIBODIES AFTER SUBTOTAL THYROIDECTOMY FOR GRAVES-DISEASE WITH FOLLICULAR THYROID-CARCINOMA
    SUGIMOTO, M
    NAKAMURA, S
    HATTORI, J
    YAMADA, T
    HORIYA, Y
    HARA, S
    SHIMA, H
    INTERNAL MEDICINE, 1993, 32 (03) : 265 - 268
  • [26] CHARACTERIZATION OF LYMPHOID-CELLS IN THE THYROID OF PATIENTS WITH GRAVES-DISEASE
    WARFORD, A
    MCLACHLAN, SM
    MALCOLM, AJ
    YOUNG, ET
    FARNDON, JR
    SMITH, BR
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1984, 57 (03): : 626 - 632
  • [27] THYROID STIMULATING IMMUNOGLOBULINS (TSI) MEASUREMENTS IN GRAVES-DISEASE PATIENTS
    KHAN, F
    ARNOLD, R
    CLINICAL RESEARCH, 1990, 38 (02): : A529 - A529
  • [28] INCREASED AGGRESSIVENESS OF THYROID-CANCER IN PATIENTS WITH GRAVES-DISEASE
    BELFIORE, A
    GAROFALO, MR
    GIUFFRIDA, D
    RUNELLO, F
    FILETTI, S
    FIUMARA, A
    IPPOLITO, O
    VIGNERI, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04): : 830 - 835
  • [29] EFFECTS OF ANTI-THYROID MEDICATIONS ON THYROID SCAN IN PATIENTS WITH GRAVES-DISEASE
    YEO, E
    CHEN, DCP
    SIEGEL, ME
    JOURNAL OF NUCLEAR MEDICINE, 1989, 30 (10) : 1748 - 1748
  • [30] TIME, CARBIMAZOLE AND THE OUTCOME OF GRAVES-DISEASE
    WILKIN, TJ
    BECK, JS
    CROOKS, J
    ISLES, TE
    GUNN, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1981, 4 (04) : 409 - 411